2 Biotech Stocks under $10 to Scoop up Now: Progenics Pharmaceuticals (NASDAQ: PGNX), IntelliPharmaCeutics International Inc. (NASDAQ: IPCI)

There is just something about an equity selling for under $10.00 a share that appeals to certain investors. Maybe it is the potential thrill of seeing a stock purchased at $8.00 a share soar to $25.00 a share in short order or just the fact that one can buy many more shares of a stock selling for $6.00 a share than one selling for $75.00 a share.
I like stocks under $10 simply because the vast majority come from the small cap arena which has been a focus area of my investing for over two decades and where most of my outsized gains have originated. It is this success and passion that led me to establish the Small Cap Gems portfolio last summer. I particularly like plumbing the small cap biotech and biopharma arenas to find these potential multi-baggers.
Some of the stocks that I originally profiled when they traded in the single digits over the last few months here at Investors Alley now comfortably trade in the mid-teens. These include ZIOPHARMA Oncology (NASDAQ: ZIOP) and Halozyme Therapeutics (NASDAQ: HALO). Hoping to find the same success here are two stocks selling for less than $10 a share that easily could be trading much higher in the foreseeable future. (more)

Please share this article